Atara Biotherapeutics IncNASDAQ:ATRANASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6610
- TODAY'S CHANGE (%)-0.0307 (-4.4383%)
- Bid / Lots0.6361/ 14
- Ask / Lots0.7230/ 5
- Open / Previous Close0.6900 / 0.6917
- Day Range
- 52 Week Range
- Volume1,626,286
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATRA |
|---|---|---|
| 09:32 ET | 31223 | 0.681 |
| 09:34 ET | 3800 | 0.68 |
| 09:36 ET | 2300 | 0.6801 |
| 09:38 ET | 500 | 0.68 |
| 09:39 ET | 3800 | 0.6875 |
| 09:41 ET | 200 | 0.6801 |
| 09:43 ET | 200 | 0.6801 |
| 09:45 ET | 400 | 0.6801 |
| 09:48 ET | 4525 | 0.69 |
| 09:50 ET | 1600 | 0.69 |
| 09:52 ET | 887 | 0.681 |
| 09:54 ET | 200 | 0.6805 |
| 09:56 ET | 300 | 0.6805 |
| 09:57 ET | 600 | 0.6805 |
| 09:59 ET | 2000 | 0.6853 |
| 10:01 ET | 14772 | 0.6894 |
| 10:03 ET | 9230 | 0.689 |
| 10:06 ET | 8052 | 0.69 |
| 10:08 ET | 8613 | 0.6807 |
| 10:10 ET | 9900 | 0.68555 |
| 10:12 ET | 15777 | 0.685 |
| 10:14 ET | 5270 | 0.6899 |
| 10:15 ET | 5434 | 0.689 |
| 10:17 ET | 18875 | 0.6949 |
| 10:19 ET | 7125 | 0.687 |
| 10:21 ET | 8419 | 0.6948 |
| 10:24 ET | 4706 | 0.6959 |
| 10:26 ET | 1749 | 0.6959 |
| 10:28 ET | 200 | 0.6901 |
| 10:30 ET | 100 | 0.6938 |
| 10:33 ET | 200 | 0.6901 |
| 10:35 ET | 10700 | 0.6901 |
| 10:37 ET | 2330 | 0.6901 |
| 10:39 ET | 1600 | 0.6901 |
| 10:42 ET | 4499 | 0.6901 |
| 10:44 ET | 7533 | 0.6901 |
| 10:46 ET | 39549 | 0.6812 |
| 10:48 ET | 3100 | 0.6812 |
| 10:50 ET | 2700 | 0.6816 |
| 10:51 ET | 3143 | 0.6896 |
| 10:53 ET | 600 | 0.682 |
| 10:55 ET | 6871 | 0.6859 |
| 10:57 ET | 4902 | 0.68585 |
| 11:00 ET | 9105 | 0.6987 |
| 11:02 ET | 5579 | 0.6923 |
| 11:04 ET | 300 | 0.683 |
| 11:06 ET | 200 | 0.6912 |
| 11:08 ET | 300 | 0.6998 |
| 11:09 ET | 13477 | 0.6988 |
| 11:11 ET | 9800 | 0.6916 |
| 11:13 ET | 8301 | 0.69155 |
| 11:15 ET | 6136 | 0.6934 |
| 11:18 ET | 1957 | 0.6953 |
| 11:20 ET | 15229 | 0.693 |
| 11:22 ET | 1600 | 0.6944 |
| 11:24 ET | 300 | 0.693 |
| 11:26 ET | 2074 | 0.693 |
| 11:27 ET | 6775 | 0.6981 |
| 11:29 ET | 3280 | 0.6981 |
| 11:31 ET | 2058 | 0.6981 |
| 11:33 ET | 6471 | 0.6954 |
| 11:36 ET | 400 | 0.6954 |
| 11:38 ET | 3179 | 0.6993 |
| 11:40 ET | 6695 | 0.7 |
| 11:42 ET | 4254 | 0.6959 |
| 11:44 ET | 6250 | 0.6954 |
| 11:45 ET | 18862 | 0.696 |
| 11:47 ET | 100 | 0.6954 |
| 11:49 ET | 400 | 0.6954 |
| 11:54 ET | 1465 | 0.70135 |
| 11:58 ET | 1103 | 0.6997 |
| 12:00 ET | 3866 | 0.6999 |
| 12:03 ET | 407 | 0.695 |
| 12:05 ET | 1915 | 0.6923 |
| 12:07 ET | 1199 | 0.687 |
| 12:09 ET | 3779 | 0.6912 |
| 12:12 ET | 2364 | 0.6827 |
| 12:14 ET | 1963 | 0.6827 |
| 12:16 ET | 300 | 0.6827 |
| 12:18 ET | 2758 | 0.6831 |
| 12:20 ET | 500 | 0.69125 |
| 12:21 ET | 600 | 0.6835 |
| 12:23 ET | 7689 | 0.68 |
| 12:25 ET | 64131 | 0.6798 |
| 12:27 ET | 2397 | 0.6797 |
| 12:30 ET | 6024 | 0.6749 |
| 12:32 ET | 2283 | 0.6796 |
| 12:34 ET | 5500 | 0.677 |
| 12:36 ET | 3456 | 0.677 |
| 12:38 ET | 700 | 0.677 |
| 12:39 ET | 93002 | 0.6616 |
| 12:41 ET | 1807 | 0.663 |
| 12:43 ET | 1673 | 0.662 |
| 12:45 ET | 13822 | 0.66 |
| 12:48 ET | 1880 | 0.6615 |
| 12:50 ET | 3512 | 0.66 |
| 12:52 ET | 4205 | 0.661 |
| 12:54 ET | 400 | 0.661 |
| 12:56 ET | 1729 | 0.66 |
| 12:57 ET | 4371 | 0.66 |
| 12:59 ET | 16944 | 0.654 |
| 01:01 ET | 13950 | 0.655 |
| 01:03 ET | 1600 | 0.6549 |
| 01:06 ET | 26968 | 0.6598 |
| 01:08 ET | 41000 | 0.66779 |
| 01:10 ET | 4130 | 0.6519 |
| 01:12 ET | 6300 | 0.66 |
| 01:14 ET | 4100 | 0.66 |
| 01:15 ET | 3038 | 0.66 |
| 01:17 ET | 9900 | 0.66 |
| 01:19 ET | 400 | 0.66365 |
| 01:21 ET | 18942 | 0.668499 |
| 01:24 ET | 2529 | 0.666947 |
| 01:26 ET | 1919 | 0.6643 |
| 01:28 ET | 4300 | 0.6684 |
| 01:30 ET | 3690 | 0.6685 |
| 01:32 ET | 3822 | 0.6755 |
| 01:33 ET | 2046 | 0.68 |
| 01:35 ET | 2094 | 0.6762 |
| 01:37 ET | 14173 | 0.6824 |
| 01:39 ET | 2607 | 0.6762 |
| 01:42 ET | 3450 | 0.6749 |
| 01:44 ET | 1716 | 0.67 |
| 01:46 ET | 2371 | 0.6762 |
| 01:48 ET | 2484 | 0.6759 |
| 01:50 ET | 2200 | 0.6762 |
| 01:51 ET | 2282 | 0.6762 |
| 01:53 ET | 3700 | 0.6764 |
| 01:55 ET | 1800 | 0.6764 |
| 01:57 ET | 5940 | 0.6769 |
| 02:00 ET | 1600 | 0.6738 |
| 02:02 ET | 1634 | 0.6824 |
| 02:04 ET | 4607 | 0.6738 |
| 02:06 ET | 1800 | 0.6738 |
| 02:08 ET | 2525 | 0.678 |
| 02:09 ET | 2700 | 0.678 |
| 02:11 ET | 1800 | 0.678 |
| 02:13 ET | 2744 | 0.6787 |
| 02:15 ET | 12312 | 0.6824 |
| 02:18 ET | 2800 | 0.6824 |
| 02:20 ET | 2413 | 0.67815 |
| 02:22 ET | 3399 | 0.682 |
| 02:24 ET | 2845 | 0.6812 |
| 02:26 ET | 2300 | 0.6831 |
| 02:27 ET | 41915 | 0.67 |
| 02:29 ET | 3585 | 0.6685 |
| 02:31 ET | 2642 | 0.667 |
| 02:33 ET | 2100 | 0.6698 |
| 02:38 ET | 1281 | 0.66 |
| 02:40 ET | 1838 | 0.66 |
| 02:42 ET | 5181 | 0.6585 |
| 02:44 ET | 2055 | 0.6585 |
| 02:45 ET | 300 | 0.6585 |
| 02:47 ET | 6163 | 0.657 |
| 02:49 ET | 3395 | 0.6603 |
| 02:51 ET | 2476 | 0.657 |
| 02:54 ET | 2664 | 0.65 |
| 02:56 ET | 3599 | 0.6505 |
| 02:58 ET | 1300 | 0.6505 |
| 03:00 ET | 498 | 0.6505 |
| 03:02 ET | 22005 | 0.6569 |
| 03:03 ET | 40815 | 0.6505 |
| 03:05 ET | 23522 | 0.651 |
| 03:07 ET | 10800 | 0.6555 |
| 03:09 ET | 66916 | 0.645 |
| 03:12 ET | 1400 | 0.645 |
| 03:14 ET | 1489 | 0.646 |
| 03:16 ET | 977 | 0.6462 |
| 03:18 ET | 3139 | 0.6502 |
| 03:20 ET | 9267 | 0.642 |
| 03:21 ET | 10079 | 0.642 |
| 03:23 ET | 3121 | 0.6422 |
| 03:25 ET | 8382 | 0.643 |
| 03:27 ET | 94300 | 0.6401 |
| 03:30 ET | 12458 | 0.6401 |
| 03:32 ET | 1514 | 0.64205 |
| 03:34 ET | 15030 | 0.6401 |
| 03:36 ET | 40582 | 0.6438 |
| 03:38 ET | 29681 | 0.65465 |
| 03:39 ET | 9663 | 0.6547 |
| 03:41 ET | 2826 | 0.6526 |
| 03:43 ET | 3201 | 0.6565 |
| 03:45 ET | 3299 | 0.6567 |
| 03:48 ET | 5598 | 0.6566 |
| 03:50 ET | 3840 | 0.6567 |
| 03:52 ET | 16110 | 0.6566 |
| 03:54 ET | 3883 | 0.6566 |
| 03:56 ET | 10777 | 0.6566 |
| 03:57 ET | 21912 | 0.6688 |
| 03:59 ET | 39694 | 0.661 |
Apr 5, 2024
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), from 4:01PM ET on Friday Apr 05, 2024 by Dow Jones
4:01PM ET on Friday Apr 05, 2024 by Dow Jones
Apr 1, 2024
DJ Atara Biotherapeutics Is Maintained at Hold by Stifel, from 11:06AM ET on Monday Apr 01, 2024 by Dow Jones
11:06AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 28, 2024
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress, from 8:30AM ET on Thursday Mar 28, 2024 by Dow Jones
8:30AM ET on Thursday Mar 28, 2024 by Dow Jones*DJ Atara Biotherapeutics 4Q Loss/Shr 56c >ATRA, from 8:30AM ET on Thursday Mar 28, 2024 by Dow Jones
8:30AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Atara Biotherapeutics Inc | 78.9M | -0.3x | --- |
Affimed NV | 78.4M | -0.7x | --- |
Curis Inc | 84.3M | -1.6x | --- |
LAVA Therapeutics NV | 71.2M | -1.7x | --- |
Ikena Oncology Inc | 64.2M | -0.8x | --- |
Cue Biopharma Inc | 75.9M | -1.4x | --- |
Company Information
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. Its pipeline products include Ebvallo (Tab-cel), ATA3219. The Company’s T-cell immunotherapy, tab-cel (tabelecleucel), is in Phase III development for patients with EBV-driven post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed rituximab or rituximab plus chemotherapy, as well as other EBV-driven diseases. Its ATA3219 is in Phase 1 development is being developed as a potential product intended to target B-cell malignancies and autoimmune diseases, based on a next generation 1XX co-stimulatory domain and the innate advantages of EBV T cells as the foundation for an allogeneic CAR T platform.
Contact Information
- Headquarters
- 2380 Conejo Spectrum St, Suite 200THOUSAND OAKS, CA, United States 91320
- Phone
- 805-623-4244
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Carol Gallagher
- President, Chief Executive Officer, Director
- Pascal Touchon
- Chief Financial Officer, Senior Vice President, Investor Relations and Finance
- Eric Hyllengren
- Executive Vice President, Chief Legal Officer
- K. Amar Murugan
- Independent Director
- Eric Dobmeier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $78.9M |
|---|---|
Revenue (TTM) | $8.6M |
Shares Outstanding | 119.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-2.61 |
Book Value | $-0.93 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 9.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,219.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
